RESUMEN
ETHNOPHARMACOLOGY RELEVANCE: The plant Typhonium trilobatum has been utilized in traditional medicine for the treatment of many ailments, including parasitic infections. Recent examinations indicate that the bioactive substances from this plant may have antiparasitic activities against Brugia malayi, which have not been determined. PURPOSE: The parasitic nematodes Brugia malayi, Brugia timori, and Wuchereria bancrofti causing lymphatic filariasis, remain a significant challenge to global public health. Given the ongoing nature of this enduring menace, the current research endeavours to examine the efficacy of an important medicinal plant, Typhonium trilobatum. METHODS: Different extracts of the T. trilobatum tubers were evaluated for their antiparasitic activity. The most prominent extract was subjected to Gas Chromatography Mass Spectrometry (GC-MS) and High Performance Liquid Chromatography (HPLC) followed by Column Chromatography for isolating bioactive molecules. The major compounds were isolated and characterized based on different spectroscopic techniques (FTIR, NMR and HRMS). Further, the antiparasitic activity of the isolated compounds was evaluated against B. malayi and compared with clinically used antifilarial drugs like Diethylcarbamazine and Ivermectin. RESULTS: The methanolic extract of the tuber exhibited significant antiparasitic activity compared to the other extracts. The bioactive molecules isolated from the crude extract were identified as Linoleic acid and Palmitic acid. Antiparasitic activity of both the compounds has been performed against B. malayi and compared with clinically used antifilarial drugs, Ivermectin and DEC. The IC50 value of Linoleic acid was found to be 6.09 ± 0.78 µg/ml after 24 h and 4.27 ± 0.63 µg/ml after 48 h, whereas for Palmitic acid the value was 12.35 ± 1.09 µg/ml after 24 h and 8.79 ± 0.94 µg/ml after 48 h. The IC50 values of both the molecules were found to be similar to the standard drug Ivermectin (IC50 value of 11.88 ± 1.07 µg/ml in 24 h and 2.74 ± 0.43 µg/ml in 48 h), and much better compared to the DEC (IC50 values of 194.2 ± 2.28 µg/ml in 24 h and 101.8 ± 2.06 µg/ml in 48 h). Furthermore, it has been observed that both the crude extracts and the isolated compounds do not exhibit any detrimental effects on the J774.A.1 macrophage cell line. CONCLUSION: The isolation and characterization of bioactive compounds present in the methanolic tuber extract of Typhonium trilobatum were explored. Moreover, the antimicrofilarial activity of the crude extracts and its two major compounds were determined using Brugia malayi microfilarial parasites without any significant side effects.
Asunto(s)
Brugia Malayi , Filariasis , Plantas Medicinales , Animales , Humanos , Filariasis/tratamiento farmacológico , Filariasis/parasitología , Ivermectina/farmacología , Ivermectina/uso terapéutico , Ácido Palmítico , Ácido Linoleico/farmacología , Extractos Vegetales/química , Antiparasitarios/farmacología , Antiparasitarios/uso terapéuticoRESUMEN
No disponible
Asunto(s)
Humanos , Femenino , Adulto , Cuerpos Extraños en el Ojo/parasitología , Filariasis/tratamiento farmacológico , Loiasis/cirugía , Antihelmínticos/uso terapéuticoRESUMEN
Introducción: las filarias son nematodos pertenecientes a la familia Filariidae, aunque existen alrededor de 200 filarias parasitas, solo unas pocas parasitan al hombre. Objetivos: realizar una breve descripción de estas parasitosis, que sirviera como guía al gran número de médicos cubanos colaboradores en países africanos, donde es particularmente frecuente este padecimiento, así como describir el comportamiento de las infecciones por filarias en pacientes atendidos en el Hospital Regional de Mouila, Gabón. Métodos: se realizó un estudio observacional, descriptivo, de corte transversal. Se incluyeron 87 pacientes de los 2 sexos, de 15 años de edad y más, en los que se logró confirmar algún tipo de filariosis. Resultados: se observó que 3,7 por ciento de los pacientes presentó una filariosis, 93,1 por ciento por Loa loa, 5,7 por ciento por Mansonella perstans y 1,1 por ciento por coinfección de ambas. El grupo de más de 65 años y el sexo femenino resultaron los más afectados. El síntoma más frecuente fue el prurito (59,8 por ciento), seguido por la poliartralgia, el dolor lumbar y la astenia. La eosinofilia se apreció en 100 por ciento y la anemia fue más frecuente en pacientes parasitados con Mansonella perstans. La intensidad de la infección para ambos tipos de filarias fue baja. En 86,1 por ciento de los pacientes tratados con dietilcarbamazina y 82,4 por ciento de los tratados con ivermectina, la respuesta fue satisfactoria. Conclusiones: Loa loa predominó, sobre todo en mujeres; el prurito, la anemia y la eosinofilia fueron las manifestaciones principales, la respuesta tratamiento con ivermectina mostró ventajas
Introduction: filariae are nematodes from the family Filariidae. There are about 200 parasitic filariae, but only a few infect humans. Objectives: make a brief description of these parasitic diseases which may serve as guidance to the large number of Cuban cooperation doctors in African countries, where this condition is particularly common, and describe the behavior of filarial infections in patients cared for at Mouila Regional Hospital in Gabon. Methods: a cross-sectional observational descriptive study was conducted of 87 patients of both sexes aged 15 and over with confirmed filariasis. Results: it was found that 3.7 percent of patients had some kind of filariasis: 93.1 percent due to Loa loa, 5.7 percent due to Mansonella perstans and 1.1 percent due to coinfection by both. Females and persons over 65 were the most affected groups. The most common symptom was pruritus (59.8 percent), followed by polyarthralgia, lumbar pain and asthenia. Eosinophilia was present in 100 percent of subjects, and anemia was more frequent in patients infected with Mansonella perstans. Infection intensity was low in both filariases. The response was satisfactory in 86.1 percent of the patients treated with diethylcarbamazine and 82.4 percent of those treated with ivermectin. Conclusions: Loa loa was predominant mainly among women. Pruritus, anemia and eosinophilia were the main manifestations. Treatment with ivermectin was found to be effective
Asunto(s)
Humanos , Masculino , Femenino , Enterobius , Filariasis/epidemiología , Filariasis/tratamiento farmacológico , Estudios Transversales , Epidemiología Descriptiva , Estudios Observacionales como AsuntoRESUMEN
Introducción: las filarias son nematodos pertenecientes a la familia Filariidae, aunque existen alrededor de 200 filarias parasitas, solo unas pocas parasitan al hombre. Objetivos: realizar una breve descripción de estas parasitosis, que sirviera como guía al gran número de médicos cubanos colaboradores en países africanos, donde es particularmente frecuente este padecimiento, así como describir el comportamiento de las infecciones por filarias en pacientes atendidos en el Hospital Regional de Mouila, Gabón. Métodos: se realizó un estudio observacional, descriptivo, de corte transversal. Se incluyeron 87 pacientes de los 2 sexos, de 15 años de edad y más, en los que se logró confirmar algún tipo de filariosis. Resultados: se observó que 3,7 por ciento de los pacientes presentó una filariosis, 93,1 por ciento por Loa loa, 5,7 por ciento por Mansonella perstans y 1,1 por ciento por coinfección de ambas. El grupo de más de 65 años y el sexo femenino resultaron los más afectados. El síntoma más frecuente fue el prurito (59,8 por ciento), seguido por la poliartralgia, el dolor lumbar y la astenia. La eosinofilia se apreció en 100 por ciento y la anemia fue más frecuente en pacientes parasitados con Mansonella perstans. La intensidad de la infección para ambos tipos de filarias fue baja. En 86,1 por ciento de los pacientes tratados con dietilcarbamazina y 82,4 por ciento de los tratados con ivermectina, la respuesta fue satisfactoria. Conclusiones: Loa loa predominó, sobre todo en mujeres; el prurito, la anemia y la eosinofilia fueron las manifestaciones principales, la respuesta tratamiento con ivermectina mostró ventajas(AU)
Introduction: filariae are nematodes from the family Filariidae. There are about 200 parasitic filariae, but only a few infect humans. Objectives: make a brief description of these parasitic diseases which may serve as guidance to the large number of Cuban cooperation doctors in African countries, where this condition is particularly common, and describe the behavior of filarial infections in patients cared for at Mouila Regional Hospital in Gabon. Methods: a cross-sectional observational descriptive study was conducted of 87 patients of both sexes aged 15 and over with confirmed filariasis. Results: it was found that 3.7 percent of patients had some kind of filariasis: 93.1 percent due to Loa loa, 5.7 percent due to Mansonella perstans and 1.1 percent due to coinfection by both. Females and persons over 65 were the most affected groups. The most common symptom was pruritus (59.8 percent), followed by polyarthralgia, lumbar pain and asthenia. Eosinophilia was present in 100 percent of subjects, and anemia was more frequent in patients infected with Mansonella perstans. Infection intensity was low in both filariases. The response was satisfactory in 86.1 percent of the patients treated with diethylcarbamazine and 82.4 percent of those treated with ivermectin. Conclusions: Loa loa was predominant mainly among women. Pruritus, anemia and eosinophilia were the main manifestations. Treatment with ivermectin was found to be effective(AU)
Asunto(s)
Humanos , Masculino , Femenino , Filariasis/tratamiento farmacológico , Filariasis/epidemiología , Enterobius , Epidemiología Descriptiva , Estudios Transversales , Estudios Observacionales como AsuntoRESUMEN
La Ivermectina, con más de 30 años de uso en humanos, es una droga que aún sigue siendo estudiada en otras indicaciones. Su seguridad es alta; se han dado casi 2.000 millones de dosis en humanos con efectos colaterales mínimos. Se excreta por las heces, no es nefrotóxica ni hepatotóxica. Es el tratamiento de elección en pacientes con SIDA, recibiendo terapia HAART para estrongiloidiasis sistémica y sarna noruega. Es empleada en niños mayores de dos años de edad o con más de 15 kilos de peso. La dosis es de 200 microgramos/kg en forma oral, al 0,6 por ciento en gotas (1 gota/kg de peso) y de 400 microgramos/kg en forma tópica al 0,1 por ciento (0,4 cc/kg de peso). Logró erradicar la oncocercosis que produce la ceguera del río y fue considerada como el triunfo de la humanidad sobre la adversidad por la OMS en 2009.
Ivermectin has been used during more than 30 years and yet it is an old drug in search for additional indications. Ivermectin has high safety profile, and more than 2 billion doses have been administered with mild side effects. Ivermectin is metabolized in the liver, and the drug or its metabolites are excreted almost exclusively in the feces over an estimated 12 days, with less than 1percent of the oral dose excreted in the urine. The plasma half-life of ivermectin in humans is approximately 18 hours following oral administration. Ivermectin is primarily metabolized by CYP3A4, and does not provoke hepato /nephrotoxicicty. This molecule is the gold standard treatment for strongyloidiasis and crusted scabies in patients with AIDS during treatment with HAART therapy. Ivermectin is used in children older than 2 years or more than 15 kg weight. Oral ivermectin 0.6 percent dose is 200 micrograms/kg (1 drop per kg) and topical ivermectin 0.1 percent dose is 400 micrograms/kg (0.4 cc per kg). Ivermectin was able to eliminate human river blindness (onchocerciasis) and represent one of the most triumphant public health campaigns ever waged in the developing world by WHO in 2009.
Asunto(s)
Humanos , Antiparasitarios/uso terapéutico , Enfermedades Cutáneas Parasitarias/tratamiento farmacológico , Ivermectina/uso terapéutico , Parasitosis Intestinales/tratamiento farmacológico , Antiparasitarios/farmacocinética , Antiparasitarios/toxicidad , Filariasis/tratamiento farmacológico , Infestaciones por Piojos/tratamiento farmacológico , Ivermectina/farmacocinética , Ivermectina/toxicidad , Larva Migrans/tratamiento farmacológicoRESUMEN
La loiasis es producida por el nematodo Loa loa, endémica en África Central y parte de África Occidental. Es transmitida por la picadura de moscas hembras del género Chrysops. Se calcula entre 3 y 13 millones de personas infectadas. Aunque la mortalidad asociada a la infección por Loa loa es baja, produce una morbilidad importante y es causa frecuente de consulta médica en las zonas endémicas. La manifestación más frecuente es el edema de Calabar, dicho edema es migratorio, no doloroso, y es producido por el paso de la filaria adulta por el tejido celular subcutáneo. Otra manifestación clínica es el paso de la filaria adulta por la conjuntiva ocular, siendo visible su desplazamiento entre la conjuntiva y la esclera ocular. El diagnóstico etiológico se establece con la demostración de microfilarias en sangre periférica, con periodicidad diurna. La PCR y la serología son otras herramientas diagnósticas. El diagnóstico diferencial de las microfilarias se debe de hacer con las otras microfilarias sanguíneas y la Onchocerca volvulus, que a veces aparece en sangre de forma ocasional. A nivel clínico, se debe diferenciar el edema de Calabar del producido por otras filariosis, gnathostomiasiso triquinosis. El tratamiento consiste en la administración de Dietilcarbamacina. El conocer las zonas geográficas de mayor prevalencia de Loa loa es útil al tratar la oncocercosis, ya que la ivermectina puede producir efectos indeseables graves a los pacientes que presenten cifras altas de microfilarias de Loa loa en sangre periférica (AU)
The loiasis is produced by the nematode Loa loa, endemic in Central Africa and part of Western Africa. It is transmitted by species of Chrysops flies. One calculates between 3 and 13 million infected people. Although the mortality associated to the infection by Loa loa is low, produces an important morbidity and is frequent cause of medical consultation in the endemic zones. The most frequent manifestation is Calabar swellings, this edema is migratory, non painful, and is produced by the passage of filaria adult by the subcutaneous cellular weave. Another clinical manifestation is the passage of filaria adult by the conjunctive, being visible its displacement between conjunctive and the ocular sclera. The aetiology diagnosis settles down with the demonstration of microfilarias in peripheral blood, with diurnal regularity. The PCR and the serology are other diagnostic tools. The diagnosis differential of the microfilarias is due to do with the other sanguineous microfilarias and the Onchocerca volvulus that same times appear in blood of occasional form. At clinical level, Calabar swellings is due to differentiate from the produced one by other filariosis, gnathostomiasis or trichinosis. The treatment consists of the administration of Dietil carbamacina. Knowing the geographiczones greater prevalence of Loa loa is useful when treatment the oncocercosis, since the ivermectina can produce serious undesirable effects to the patients who present high numbers of microfilarias of Loa loa in peripheral blood (AU)
Asunto(s)
Humanos , Loiasis/epidemiología , Loa/patogenicidad , Filariasis/tratamiento farmacológico , Microfilarias/patogenicidad , Enfermedades Endémicas/estadística & datos numéricos , Dietilcarbamazina/uso terapéuticoRESUMEN
Os autores realizaram uma ampla revisão sobre o tratamento da filariose bancroftiana com a droga dietilcarbamazina. Os aspectos interessantes sobre o histórico de sua descoberta e os conceitos básicos de sua farmacologia foram relatados de forma resumida. Ênfase especial, por outro lado, foi dada às especulações feitas pelos diversos autores sobre os achados intrigantes descritos na literatura. Foram trazidos os novos avanços sobre o conhecimento da doença, como por exemplo, a visualização pela ultra-sonografia do verme vivo de Wuchereria bancrofti, no seu hospedeiro natural, o homem. Isso possibilitou a compreensão de muitos dos achados aparentemente paradoxais encontrados na literatura sobre o tratamento da infeção com a DEC. Assim, devido à inexistência de uma droga sucessora que reunisse efeitos micro e macrofilaricidas ideais e aos novos conhecimentos sobre a bancroftose e sobre a própria dietilcarbamazina, foi-lhe conferido um novo realce. Esses aspectos a colocaram numa posição de destaque no cenário da infecção, à época do seu quase cinqüentenário de existência.
The authors presented a detailed review about the treatment of bancroftian filariasis with diethylcarbamazine. The interesting aspects about the drug discovery and the basic concepts about its pharmacology were reported in a summarised form. On the other hand, emphasis was made about the speculation done by several authors about the intriguing findings regarding its efficacy reported in the literature. Latter, it was brought the new advances about the disease, as for example, the visualization by ultrasound of living Wuchereria bancrofti adult worm on its natural host--the human being. This made possible the comprehension of several paradoxical issues reported, focusing the treatment of infection using diethylcarbamazine. So far, because of the lack of ideal drug with micro and macrofilaricidal properties, together with the new understand about the disease and the new parameters for monitoring the efficacy of the drug, diethylcarbamazine has back its importance conquered at the begin of its discovery, almost fifth years ago.
Asunto(s)
Dietilcarbamazina/uso terapéutico , Filaricidas/uso terapéutico , Filariasis/tratamiento farmacológico , Wuchereria bancrofti , Animales , Dietilcarbamazina/efectos adversos , Dietilcarbamazina/farmacocinética , Dietilcarbamazina/farmacología , Filaricidas/efectos adversos , Filaricidas/farmacocinética , Filaricidas/farmacología , Filariasis/parasitología , Humanos , Microfilarias/efectos de los fármacos , Recurrencia , Wuchereria bancrofti/efectos de los fármacosRESUMEN
A microfilaria survey was conducted in Blanchisseuse, North Trinidad in 1992 twelve years after mass treatment with spaced doses of diethylcarbamazine citrate (DEC-C) for the control of Bancroftian filariasis; 348 persons were examined, including 104 who had participated in the mass-chemotherapy campaign in 1980. No W. bancrofti microfilarie were detected among 66 percent of the population examined. In 1980, 86 persons were found with W. bancrofti, 140 with M. ozzardi and 44 with mixed infections while in 1992 only Mansonella ozzardi infections persisted despite DEC-C treatment. From the 104 persons re-examined, 46 persons had M.ozzardi, of which 5 were new cases but none had W. bancrofti infections in 1992. During both the 1980 and 1992 surveys, low microfilariae rates of M.ozzardi were observed among the 1-4, 5-9 and 10-19-year age groups. From the 302 persons examined in 1992, 29 were infected, with significantly (p<0.001) more males (79.3 percent) than females (20.7 percent) being microfilaraemic. The combined results showed similar prevalence rates of M.ozzardi from 23.3 percent to 21.6 percent in 1980 and 1992, respectively. A good correlation was found between the results observed from Nucleopore membrane filtration and thick blood films. The usefulness of thes methods and spaced treatment using DEC-C is also discussed (AU)
Asunto(s)
Humanos , Dietilcarbamazina/uso terapéutico , Wuchereria bancrofti , Mansonella , Filariasis/tratamiento farmacológico , Microfilarias , Trinidad y TobagoRESUMEN
O autor relata dois casos de erupçäo cutânea, extremamente pruriginosa, com eosinofilia importante e concomitante com infestaçäo por S.stercoralis (Larva currens).
Asunto(s)
Humanos , Masculino , Adulto , Filariasis/patología , Manifestaciones Cutáneas , Enfermedades Transmisibles/patología , Filariasis/diagnóstico , Filariasis/tratamiento farmacológico , Filarioidea/patogenicidad , Larva/patogenicidadRESUMEN
A infecçäo filariana foi caracterizada em seus aspectos clínicos e parasitológicos no fim do século passado. Somente em 1939, foi sugerida a possibilidade de uma correlaçäo entre infecçäo por filárias e sintomatologia respiratória. Entre os anos de 1953 e 1987, foram observados, no Centro de Asma e Alergia do Recife, consecutivamente, 167 pacientes com eosinofilia tropical pulmonar, diagnosticados com base nos seguintes critérios: 1. sintomatología respiratória persistente; 2. eosifilia circulante > ou = 2.000/m3; 3. cura pela dietilcarbamazina; 4. testes sorológicos positivos para anticorpos antifilária. Pertenciam ao sexo masculino 116 pacientes e ao feminino 51, com predominância de homens de 2,27 : 1. A idade variou entre 2 e 71 anos (média 31 anos) e a duraçäo da doença entre 1 e 120 meses (média 16 meses). A pesquisa de anticorpos circulantes, mediante a técnica da imunofluorescência modificada por Gonzaga, foi realizada em 71 pacientes com sintomas típicos da síndrome, sendo positiva em todos e, na maioria, com títulos elevados. Nos grupos controles, residentes em áreas endêmicas para filariose, a positividade foi observada em 25% dos casos, foi normal em dois, de padräo prevalentemente obstrutivo em 15, restritivo em nove e misto em quatro. Com relaçäo à etiopatogênese, com base nos achados do presente trabalho e outras evidências da literatura, a síndrome é considerada uma conseqüência da hipersensibilidade do hospedeiro aos determinantes antigênicos da microfilária. Sugere-se a denominaçäo filariose pulmonar alérgica, que indica o agente etiológico e o mecanismo patogenético